69 related articles for article (PubMed ID: 14965711)
1. C-myc oncoprotein expression and gene amplification in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Naase M; Wells CA
Breast; 2002 Dec; 11(6):466-72. PubMed ID: 14965711
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
3. c-erbB2 oncoprotein expression, gene amplification, and chromosome 17 aneusomy in apocrine adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
J Pathol; 2000 Jun; 191(2):138-42. PubMed ID: 10861572
[TBL] [Abstract][Full Text] [Related]
4. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes, granules and breast cancer: what has c-myc to do with apocrine changes?
Schmitt FC; Reis-Filho JS
Breast; 2002 Dec; 11(6):463-5. PubMed ID: 14965710
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast.
Elayat G; Selim AG; Gorman P; Tomlinson I; Wells CA
Pathol Res Pract; 2011 Feb; 207(2):75-8. PubMed ID: 21159451
[TBL] [Abstract][Full Text] [Related]
7. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
[TBL] [Abstract][Full Text] [Related]
8. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Histopathology; 2009 Feb; 54(3):348-54. PubMed ID: 19236511
[TBL] [Abstract][Full Text] [Related]
10. c -MYC amplification and expression in astrocytic tumors.
Faria MH; Khayat AS; Burbano RR; Rabenhorst SH
Acta Neuropathol; 2008 Jul; 116(1):87-95. PubMed ID: 18369647
[TBL] [Abstract][Full Text] [Related]
11. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
[TBL] [Abstract][Full Text] [Related]
12. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
[TBL] [Abstract][Full Text] [Related]
13. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
14. The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.
Corzo C; Corominas JM; Tusquets I; Salido M; Bellet M; Fabregat X; Serrano S; Solé F
Cancer Genet Cytogenet; 2006 Mar; 165(2):151-6. PubMed ID: 16527609
[TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration cytology of apocrine adenosis of the breast: report on three cases.
Watanabe K; Nomura M; Hashimoto Y; Hanzawa M; Hoshi T
Diagn Cytopathol; 2007 May; 35(5):296-9. PubMed ID: 17427223
[TBL] [Abstract][Full Text] [Related]
16. Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer.
Varga Z; Zhao J; Ohlschlegel C; Odermatt B; Heitz PU
Histopathology; 2004 Apr; 44(4):332-8. PubMed ID: 15049898
[TBL] [Abstract][Full Text] [Related]
17. MYC amplification and TERT expression in breast tumor progression.
Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
[TBL] [Abstract][Full Text] [Related]
18. Negative implication of C-MYC as an amplification target in esophageal cancer.
Huang XP; Rong TH; Wang JY; Tang YQ; Li BJ; Xu DR; Zhao MQ; Zhang LJ; Fang Y; Su XD; Liang QW
Cancer Genet Cytogenet; 2006 Feb; 165(1):20-4. PubMed ID: 16490593
[TBL] [Abstract][Full Text] [Related]
19. c-myc amplifications in primary breast carcinomas and their local recurrences.
Aulmann S; Adler N; Rom J; Helmchen B; Schirmacher P; Sinn HP
J Clin Pathol; 2006 Apr; 59(4):424-8. PubMed ID: 16497871
[TBL] [Abstract][Full Text] [Related]
20. The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer.
Hyun CL; Lee HE; Kim KS; Kim SW; Kim JH; Choe G; Park SY
J Clin Pathol; 2008 Mar; 61(3):317-21. PubMed ID: 17761736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
